Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Anthropic quickly finds itself already inside more than 80 ETFs (SeekingAlpha) +++ ANTHROPIC Aktie +3,79%

ELANCO Aktie

 >ELANCO Aktienkurs 
23.52 EUR    -1.9%    (TradegateBSX)
Ask: 23.59 EUR / 850 Stück
Bid: 23.47 EUR / 860 Stück
Tagesumsatz: 59 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELANCO Aktie über LYNX handeln
>ELANCO Performance
1 Woche: -0,1%
1 Monat: +14,4%
3 Monate: +14,9%
6 Monate: +40,2%
1 Jahr: +27,9%
laufendes Jahr: +24,0%
>ELANCO Aktie
Name:  ELANCO ANIMAL HEALTH.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US28414H1032 / A2N6BH
Symbol/ Ticker:  5EA (Frankfurt) / ELAN (NYSE)
Kürzel:  FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN
Index:  -
Profil:  Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain ..
>Volltext..
Marktkapitalisierung:  11986.4 Mio. EUR
Unternehmenswert:  14848.63 Mio. EUR
Umsatz:  4695.88 Mio. EUR
EBITDA:  988.8 Mio. EUR
Nettogewinn:  -134.09 Mio. EUR
Gewinn je Aktie:  -0.27 EUR
Schulden:  3381.44 Mio. EUR
Liquide Mittel:  424.16 Mio. EUR
Operativer Cashflow:  560.08 Mio. EUR
Bargeldquote:  0.26
Umsatzwachstum:  16.15%
Gewinnwachstum:  -522.97%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ELANCO
Letzte Datenerhebung:  20.11.26
>ELANCO Kennzahlen
Aktien/ Unternehmen:
Aktien: 499.83 Mio. St.
Frei handelbar: 98.98%
Rückkaufquote: -
Mitarbeiter: 9900
Umsatz/Mitarb.: 0.43 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 18.59%
Bewertung:
KGV: -
KGV lG: 22.44
KUV: 2.32
KBV: 2.06
PEG-Ratio: -
EV/EBITDA: 15.02
Rentabilität:
Bruttomarge: 45.3%
Gewinnmarge: -2.86%
Operative Marge: 7.58%
Managementeffizenz:
Gesamtkaprendite: -1.09%
Eigenkaprendite: -2.2%
>ELANCO Peer Group
Gesundheit, Hauterkrankungen & -behandlung/ Dermatologie, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Tiermedizin/ Tierbehandlung
 
19.11.26 - 12:45
Elanco Announces Inaugural $600 Million Share Repurchase Authorization (PR Newswire)
 
Reflects Strengthening Financial Profile, Strong Cash Flow Generation, Successful Balance Sheet De-Leveraging Below 3x, and Confidence in Continued Momentum INDIANAPOLIS, Nov. 19, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today its Board of Directors......
19.11.26 - 12:45
Elanco sets $600M stock buyback plan (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.11.26 - 14:24
Elanco to Participate in Upcoming Investor Conferences (PR Newswire)
 
INDIANAPOLIS, Nov. 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor conferences. On Monday, November 30, Jeff Simmons, president and CEO, will participate in a fireside chat at the 9th Annual......
09.11.26 - 20:18
Elanco auf der UBS Healthcare-Konferenz: Höheres Wachstum, steigende Margen und beschleunigter Schuldenabbau (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
09.11.26 - 12:48
Elanco Animal Health: 3 Key Takeaways for Long-Term Investors (Fool)
 
Elanco's pricing held firm in Q3 while rivals discounted, a choice that tests whether proprietary products can continue to win share without cutting prices....
07.11.26 - 00:36
Elanco Shares Jump After Q3 Beat and Outlook Raise (Bloomberg)
 
Elanco Animal Health shares rose nearly 8% after the company reported third-quarter earnings above expectations and raised its full-year outlook. Jeff Simmons, Elanco's President and CEO, called it a high-quality quarter, citing 11% reported growth and broad strength across markets and product lines. He speaks with Romaine Bostick & Kailey Leinz on "The Close." (Source: Bloomberg)...
06.11.26 - 19:36
Elanco (ELAN) Q3 2026 Earnings Call Transcript (Fool)
 
Elanco beat expectations and raised guidance on strong innovation sales....
06.11.26 - 16:45
Elanco Animal Health (ELAN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
06.11.26 - 15:15
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
 
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +35.00% and +4.91%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?...
06.11.26 - 12:33
Elanco Non-GAAP EPS of $0.27 beats by $0.07, revenue of $1.27B beats by $60M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.26 - 12:30
October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority (PR Newswire)
 
Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines Purchasing INDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN), today released findings from its......
06.11.26 - 12:30
Elanco Animal Health Reports Third Quarter 2026 Results (PR Newswire)
 
Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone Third Quarter 2026 Financial Results:Revenue of $1.265 billion, an increase of 11% year-over-year; 9%......
05.11.26 - 14:24
Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch (24/7 Wall St.)
 
One stock has soared more than sevenfold this year, another just lost a quarter of its value on leaked data, and a third carries the fate of millions of retirees. Friday's earnings could test each rally in very different ways....
03.11.26 - 13:57
Elanco to Participate in UBS Global Healthcare Conference (PR Newswire)
 
INDIANAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital......
30.10.26 - 16:30
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
 
Elanco Animal Health (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
29.10.26 - 14:42
Caring for Both Ends of the Leash: Elanco and The Veterinary Cooperative Support The Street Dog Coalition (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / October 29, 2026 / At Elanco, we believe that making life better for animals, makes life better. That includes every pet, whatever their owner's circumstances. T......
27.10.26 - 14:42
Elanco: Addressing Critical Health Needs Through Innovation (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / October 27, 2026 / Innovation in animal health is about more than developing something new; it's about understanding what animals need, identifying where current......
22.10.26 - 12:57
Elanco Animal Health Appoints Jamie Preston as Chief People Officer (PR Newswire)
 
Preston brings more than two decades of global HR leadership and workforce innovation experience; Dave Kinard to retire at year-end INDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Jamie Preston as Executive Vice......
20.10.26 - 14:51
Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
20.10.26 - 14:48
Jefferies stuft Zoetis und Elanco wegen Preissetzungsrisiken ab – IDEXX bleibt Favorit (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Unrat ist nicht das Gegenteil von Rat. - Dr. Fritz P. Rinnhofer
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!